1-o-hexadecyl-2-n-methylcarbamylphosphatidylcholine has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.70) | 18.7374 |
| 1990's | 10 (43.48) | 18.2507 |
| 2000's | 10 (43.48) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fertel, RH; Li, Q; Sprecher, H; Travers, JB | 1 |
| Harper, MJ; Kasamo, M; Kudolo, GB | 1 |
| Ellis, JM; Marx, MH; O'Flaherty, JT; Piantadosi, C; Redman, JF; Schmitt, JD; Surles, JR; Wykle, RL | 1 |
| Banks, JB; Lumb, RH; O'Flaherty, JT; Wykle, RL | 1 |
| Harper, MJ; Kudolo, GB; Newton, ER; Norris, CJ; Peairs, WA | 1 |
| Bazan, NG; Clark, GD; Kato, K; Zorumski, CF | 1 |
| Chilvers, ER; Condliffe, AM; Haslett, C; Kitchen, E; Rossi, AG | 1 |
| Nishioka, Y; Tokumura, A; Tsukatani, H; Tsutsumi, T | 1 |
| Bix, GJ; Clark, GD | 1 |
| Kawano, Y; Matsui, N; Miyakawa, I; Narahara, H; Nasu, K; Tanaka, Y | 1 |
| Brinkley, BR; Clark, GD; McNeil, RS; Swann, JW | 1 |
| Kato, K | 1 |
| Arima, K; Fujisawa, K; Miyakawa, I; Narahara, H; Nasu, K; Sugano, T | 1 |
| Bianchi, L; Cellai, C; Della Malva, N; Laurenzana, A; Paoletti, F; Vannucchi, AM | 1 |
| Barbuti, A; Feinmark, SJ; Ishii, S; Robinson, RB; Shimizu, T | 1 |
| Lee, RK; Teather, LA; Wurtman, RJ | 1 |
| Johnston, JM; Kawano, Y; Miyakawa, I; Narahara, H; Nasu, K; Yoshimatsu, J | 1 |
| Chlopicki, S; Jakubowski, A; Olszanecki, R | 1 |
| Bazan, HE; Bazan, NG; Ma, X; Ottino, P | 1 |
| Akira, S; Ishii, S; Shimizu, T; Shindou, H; Takeda, K; Yamamoto, M | 1 |
| Bellizzi, MJ; Gelbard, HA; Lu, SM; Masliah, E | 1 |
| Fukuda, J; Furukawa, Y; Kawano, Y; Matsumoto, H; Narahara, H; Yuge, A | 1 |
| Ajiro, Y; Giles, WR; Saegusa, N; Spitzer, KW; Stafforini, DM | 1 |
23 other study(ies) available for 1-o-hexadecyl-2-n-methylcarbamylphosphatidylcholine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
| Article | Year |
|---|---|
Binding of carbamyl-platelet-activating factor to the Raji lymphoblast platelet-activating factor receptor.
Topics: Burkitt Lymphoma; Humans; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tritium; Tumor Cells, Cultured | 1992 |
Autoradiographic localization of platelet-activating factor (PAF) binding sites in the rabbit endometrium during the peri-implantation period.
Topics: Animals; Autoradiography; Binding Sites; Blastocyst; Embryo Implantation; Endometrium; Female; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pregnancy; Rabbits; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1991 |
1-O-alkyl-2-N-methylcarbamyl-glycerophosphocholine: a biologically potent, non-metabolizable analog of platelet-activating factor.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; In Vitro Techniques; Leukotriene B4; Neutrophils; Phospholipases A; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Stereoisomerism; Structure-Activity Relationship | 1987 |
Evidence for protein-catalyzed transfer of platelet activating factor by macrophage cytosol.
Topics: Animals; Biological Transport; Cattle; Cytosol; Intracellular Membranes; Kinetics; Macrophages; Organ Specificity; Phospholipid Ethers; Platelet Activating Factor; Proteins; Rabbits | 1988 |
Platelet-activating factor antagonists and implantation in rabbits.
Topics: Animals; Drug Administration Schedule; Embryo Implantation; Female; Phospholipid Ethers; Platelet Activating Factor; Pregnancy; Rabbits | 1994 |
Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation.
Topics: Action Potentials; Animals; Azepines; Diterpenes; Ginkgolides; Hippocampus; In Vitro Techniques; Lactones; Long-Term Potentiation; Male; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tetrazoles; Thienopyridines; Triazoles | 1994 |
Demonstration of reversible priming of human neutrophils using platelet-activating factor.
Topics: Adult; Azepines; Cell Adhesion; Cell Polarity; Cell Size; Cells, Cultured; Dihydropyridines; Enzyme Activation; Humans; Imidazoles; Macrophage-1 Antigen; Microspheres; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophils; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Respiratory Burst; Superoxides; Time Factors; Triazoles; Tumor Necrosis Factor-alpha | 1996 |
Exogenously added alkylmethylglycerophosphocholine and alkylmethylcarbamylglycerophosphocholine accumulate in plasma membranes more than in intracellular membranes of rabbit platelets.
Topics: Animals; Blood Platelets; Cell Membrane; Intracellular Membranes; Phosphatidylcholines; Phospholipid Ethers; Platelet Activating Factor; Rabbits; Serum Albumin, Bovine; Stimulation, Chemical; Tritium | 1997 |
Platelet-activating factor receptor stimulation disrupts neuronal migration In vitro.
Topics: Animals; Anti-Asthmatic Agents; Cell Movement; Cells, Cultured; Cerebellum; Dioxolanes; Diterpenes; Ginkgolides; Lactones; Neurons; Phospholipid Ethers; Platelet Activating Factor; Rats; Rats, Sprague-Dawley | 1998 |
Platelet-activating factor stimulates cytokine production by human endometrial stromal cells.
Topics: Adult; Cell Line; Chemokine CCL3; Chemokine CCL4; Cytokines; Endometrial Neoplasms; Endometrium; Female; Humans; Interleukin-6; Interleukin-8; Macrophage Colony-Stimulating Factor; Macrophage Inflammatory Proteins; Phospholipid Ethers; Platelet Activating Factor; Sarcoma; Stromal Cells; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1999 |
Neuronal cytoskeletal alterations evoked by a platelet-activating factor (PAF) analogue.
Topics: Actins; Animals; Cells, Cultured; Cytochalasin D; Cytoskeleton; Fluorescent Antibody Technique, Indirect; Microtubules; Mitochondria; Neurites; Neurons; Nocodazole; Paclitaxel; Phospholipid Ethers; Platelet Activating Factor; Polymers; Rats; Rats, Sprague-Dawley | 1999 |
Modulation of long-term potentiation in the CA1 area of rat hippocampus by platelet-activating factor.
Topics: Animals; Diterpenes; Electric Stimulation; Ginkgolides; Hippocampus; In Vitro Techniques; Lactones; Long-Term Potentiation; Male; Neurotransmitter Agents; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1999 |
Effects of platelet-activating factor on cytokine production by human uterine cervical fibroblasts.
Topics: Cells, Cultured; Cervix Uteri; Chemokine CCL2; Chemokine CCL5; Female; Fibroblasts; Gene Expression; Humans; Interleukin-6; Interleukin-8; Phospholipid Ethers; Platelet Activating Factor; RNA, Messenger | 2001 |
Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Differentiation; Cell Division; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Histones; HL-60 Cells; Humans; K562 Cells; Kinetics; Leukemia; Leukemia, Erythroblastic, Acute; Mice; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Triazoles; Tumor Cells, Cultured | 2002 |
Block of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor.
Topics: Action Potentials; Animals; Arachidonic Acids; Arrhythmias, Cardiac; Barium; Electric Conductivity; Electrophysiology; Enzyme Inhibitors; Heart; Heart Ventricles; Membrane Potentials; Mice; Mice, Knockout; Nerve Tissue Proteins; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Tandem Pore Domain; Protein Kinase C; Protons; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Zinc | 2002 |
Platelet-activating factor increases prostaglandin E(2) release from astrocyte-enriched cortical cell cultures.
Topics: Animals; Arachidonic Acid; Astrocytes; Binding Sites; Cells, Cultured; Cerebral Cortex; Dinoprostone; Diterpenes; Drug Synergism; Female; Ginkgolides; Lactones; Osmolar Concentration; Phospholipid Ethers; Platelet Activating Factor; Pyridinium Compounds; Rats; Solvents | 2002 |
Platelet-activating factor inhibits the secretion of platelet-activating factor acetylhydrolase by human decidual macrophages.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Calcium; Cells, Cultured; Decidua; Female; Flow Cytometry; Humans; Macrophages; Phospholipid Ethers; Platelet Activating Factor; Protein Kinase C | 2003 |
Involvement of platelet activating factor in immediate heart response to lipopolysaccharide.
Topics: Animals; Azepines; Cell Line; Dose-Response Relationship, Drug; Enzyme Induction; Escherichia coli; Lipopolysaccharides; Macrophages; Membrane Proteins; Mice; Myocardial Contraction; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phospholipid Ethers; Platelet Activating Factor; Rats; Receptors, Leukotriene; Receptors, Thromboxane A2, Prostaglandin H2; Triazoles | 2004 |
Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Topics: Animals; Antibodies; Azepines; Cattle; Cell Division; Cell Movement; Cells, Cultured; Corneal Neovascularization; Dose-Response Relationship, Drug; Endothelial Cells; Fibroblast Growth Factor 2; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; RNA, Messenger; Skin; Thienopyridines; Triazoles; Umbilical Veins; Up-Regulation; Vascular Endothelial Growth Factor A | 2004 |
Priming effect of lipopolysaccharide on acetyl-coenzyme A:lyso-platelet-activating factor acetyltransferase is MyD88 and TRIF independent.
Topics: Acetyl Coenzyme A; Acetyltransferases; Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Animals; Antigens, Differentiation; Cells, Cultured; Enzyme Activation; Female; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Myeloid Differentiation Factor 88; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Kinase Inhibitors; Receptors, G-Protein-Coupled; Receptors, Immunologic; Signal Transduction; Toll-Like Receptor 4 | 2005 |
Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor.
Topics: AIDS Dementia Complex; Animals; Calcium; Caspases; Dendritic Spines; Electric Stimulation; Hippocampus; Humans; Long-Term Potentiation; Male; Neurons; Organ Culture Techniques; Perfusion; Phospholipid Ethers; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Synaptic Transmission | 2005 |
The effects of platelet-activating factor on the secretion of interleukin-8 and growth-regulated oncogene alpha in human immortalized granulosa cell line (GC1a).
Topics: Azepines; Cell Line; Chemokine CXCL1; Enzyme-Linked Immunosorbent Assay; Female; Granulosa Cells; Humans; Interleukin-8; Ovulation; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Triazoles | 2007 |
Platelet-activating factor stimulates sodium-hydrogen exchange in ventricular myocytes.
Topics: Acidosis; Alkalosis; Animals; Azepines; Benzophenanthridines; Dose-Response Relationship, Drug; Flavonoids; Guanidines; Guinea Pigs; Heart Ventricles; Hydrogen-Ion Concentration; Indoles; Ion Transport; Maleimides; Mitogen-Activated Protein Kinase Kinases; Myocytes, Cardiac; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Kinase C; Protein Kinase Inhibitors; Receptors, G-Protein-Coupled; Signal Transduction; Sodium; Sodium-Hydrogen Exchangers; Spectrometry, Fluorescence; Sulfones; Time Factors; Triazoles | 2011 |